Cutler Group LP Enveric Biosciences, Inc. Put Options Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
About Enveric Biosciences, Inc.
- Ticker ENVB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,078,270
- Market Cap $665K
- Description
- Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...